摘要:
Provided is a composition for improving blood circulation, comprising an extract of Lindera obtusiloba as an active ingredient, and more specifically, to a pharmaceutical composition and a health functional food for preventing and treating thrombolic disorders by improving blood circulation, comprising an extract of Lindera obtusiloba as an active ingredient. The extract of Lindera obtusiloba of the present invention and a crude purified product thereof can be obtained through extraction using various solvents such as water, ethanol, methanol, butanol, etc. Since the extract and the crude purified product have not only excellent inhibitory effect on platelet aggregation induced by various aggregation inductions in vitro, but also excellent inhibitory effect on rapid thrombus formation in vivo, they can be useful for preventing and treating diseases caused by blood circulation disorders such as thromboembolism, etc.
摘要:
The invention relates to novel dyes of the formula (1) in which D represents a phenyl or naphthalene residue which is substituted by one or two sulphonic Acid or carboxylic acid groups and, optionally, by one or two groups selected from C1-C4alkyl, hydroxyl and nitro, each R1 and R2, independently, represent hydrogen or, a C1-C4alkyl group, R'1 represents hydrogen, hydroxyl, C1-C4alkyl or C1-C4hydroxyalkyl, R3 represents hydrogen, C1-C4alkyl or phenyl, which is unsubstituted or substituted by one or two groups selected from C1-C4alkyl, C1-C4alkoxy, halogen, hydroxyl, -NH2, nitro, -SO3M and -CO2M and M represents hydrogen, an alkaline or alkaline earth metal, ammonium or ammonium that is mono-, di-, tri- or tetrasubstituted by C1-C4alkyl or C2-C4hydroxyalkyl or a polyglycolammonium cation and also known dyes of formula (5), in which D' represents a phenyl or naphthalene residue which is substituted by one or two sulphonic acid or carboxylic acid groups and, optionally, by one or two groups selected from C1-C4alkyl and C1-C4alkoxy and R3 and M are as defined above, and their mixtures suitable for shading white paper, a process for shading, a process for the preparation of the novel dyes and white paper which has been treated with such shading components.
摘要:
This invention covers a novel process for the preparation of carnitine esters of starch and other hydroxy polymers from β-lactone of carnitine and their use as additives in the manufacture of paper, paperboard or cardboard, in waste water treatment, as a textile sizing agent and in cosmetic or pharmaceutical compositions.
摘要:
Electrophotographic photoreceptor capable of forming a high quality image in various environments, with which image defects such as black spots or color spots hardly occur, an image forming apparatus using such a photoreceptor, and an electrophotographic cartridge using such a photoreceptor. The electrophotographic photoreceptor comprises an electroconductive substrate, an undercoat layer containing a binder resin and metal oxide particles having a refractive index of at least 2.0 formed on the electroconductive substrate, and a photosensitive layer formed on the undercoat layer, characterized by satisfying the following (1) or (2): (1) the ratio of the specular reflection of the undercoat layer calculated as a thickness of 2 µm to a light having a wavelength of 480 nm, to the specular reflection of the electroconductive substrate to a light having a wavelength of 480 nm, is at least 50%, or (2) the ratio of the specular reflection of the undercoat layer calculated as a thickness of 2 um to a light having a wavelength of 400 nm, to the specular reflection of the electroconductive substrate to a light having a wavelength of 400 nm, is at least 50%.
摘要:
The present invention relates to a combination comprising: a magnet; and a magnetic cell comprising: a cell having integrin on a surface thereof; and
a magnetic particle comprising a peptide having an adhesive activity for integrin and a magnetic material, wherein an amount of coating of the peptide onto the magnetic particles is from 3 ng to 6.6 µg based on 1 mg of the magnetic particle.
摘要:
The present invention relates to an agent for treating a corneal disorder, the agent comprising the following components: (1) a peptide consisting of the amino acid sequence represented by Ser-Ser-Ser-Arg-Arg, Gly-Ser-Ser-Ser-Arg, Gly-Ser-Ser-Ser-Arg-Arg, Ala-Ser-Ser-Ser-Arg-Arg-Ala-Pro, Gly-Ser-Ser-Ser-Arg-Ala-Ala-Pro, Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro or Gly-Ser-Ser-Ser-Arg-Ala-Ala-Ala-Pro or pharmaceutically acceptable salts thereof and, (2) a peptide consisting of the amino acid sequence represented by Phe-Gly-Leu-Met-NH2 or substance P or pharmaceutically acceptable salts thereof.